FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely pharmacology, urology, and can be used for the prevention and treatment of urate nephropathy. The use of the tripeptide Leu-Ile-Lys as a means for pharmacological correction of urate nephropathy is proposed. The tripeptide Lys-Leu-Lys has a pronounced anti-lithogenic activity, has an antioxidant effect and can be used as a remedy to treat urate nephropathy at a dose of 11.5 mg/kg.
EFFECT: expanding the range of pharmacological agents for the treatment of urate nephropathy.
1 cl, 3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACOLOGICAL AGENT FOR URINARY STONE DISEASE TREATMENT | 2018 |
|
RU2679120C1 |
| METHOD OF PROTEOMIC CORRECTION OF OXALATE NEPHROLITHIASIS | 2019 |
|
RU2704022C1 |
| REMEDY FOR THE TREATMENT OF URATE NEPHROLITHIASIS | 2021 |
|
RU2762139C1 |
| AGENT ANTILITAL POSSESSING ANTILITOGENIC ACTION | 2012 |
|
RU2484834C1 |
| METHOD FOR PREDICTING URATE NEPHROLITHIASIS | 2021 |
|
RU2759237C1 |
| PROCESS FOR PREPARATION OF A PEPTIDE AGENT WITH ANTILITHOGENIC EFFECT | 2017 |
|
RU2652339C1 |
| PHARMACOLOGICAL AGENT FOR THE TREATMENT OF GASTRIC ULCER | 2018 |
|
RU2688187C1 |
| AGENT STIMULATING FILTRATION AND EXCRETORY FUNCTION OF KIDNEY AT TOXIC NEPHROPATHOLOGY | 1992 |
|
RU2008912C1 |
| HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
| METHOD OF TREATING ACUTE PERIODONTITIS | 2018 |
|
RU2684290C1 |
